Skip to main content
Clinical Trials/NCT04366986
NCT04366986
Completed
Not Applicable

International Registry of Coronavirus Exposure in Pregnancy (IRCEP)

Pregistry1 site in 1 country17,318 target enrollmentJune 23, 2020
ConditionsCovid-19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid-19
Sponsor
Pregistry
Enrollment
17318
Locations
1
Primary Endpoint
Birth outcomes
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The International Registry of Coronavirus Exposure in Pregnancy (IRCEP) is a prospective cohort study of pregnant and recently pregnant women who have been tested for SARS-CoV-2 (regardless of the result) or have been clinically diagnosed with COVID-19 by a health care professional. Data from the IRCEP will be used to evaluate the impact of COVID-19 on pregnancy and birth outcomes.

Detailed Description

The International Registry of Coronavirus Exposure in Pregnancy (IRCEP) will enroll women 18 years of age and older who are currently pregnant or have been pregnant women within the last 6 months, and who have been tested for SARS-CoV-2 (regardless of the result) or have been clinically diagnosed with COVID-19 by a health care professional. As this is an international registry, women from all countries are welcome to participate. Women will enroll and provide information to the IRCEP via website and mobile app. After signing the electronic informed consent document, registrants will answer questions on the following modules: Demographics, Reproductive History, Height and Weight, Habits, Health Conditions, Medications, Current Pregnancy, COVID-19 Infection Test, and COVID-19 Infection Symptoms. Monthly follow-up modules will continue until the pregnancy outcome. In case of a live birth, the Registry participant will continue with the Post-Partum Outcomes module until the newborn is 90 days of age. Medical records from the mother and neonate will also be requested.

Registry
clinicaltrials.gov
Start Date
June 23, 2020
End Date
August 31, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Pregistry
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Pregnant women or women who have been pregnant within the last 6 months
  • Able to give electronic informed consent
  • Tested for SARS-CoV-2 (regardless of the result) or clinically diagnosed with COVID-19 by a health care professional

Exclusion Criteria

  • \<18 years of age

Outcomes

Primary Outcomes

Birth outcomes

Time Frame: Birth to 90 days post-partum

Length at birth in centimeters

Pregnancy outcomes

Time Frame: 1 year

Miscarriage (or spontaneous abortion), Elective termination, Stillbirth, Preterm delivery

Study Sites (1)

Loading locations...

Similar Trials